Global Mycoplasma Testing Market is expected to grow at a CAGR of 12.5% during the forecast period 2020-2027

A new research report published by Fior Markets with the title Mycoplasma Testing Market by Technology (Enzymatic Methods, Microbial Culture Techniques, Indirect Assay, Direct Assay, ELISA, PCR), Application (End of Production Cells Testing, Virus Testing, Cell Line Testing), Region, Global Industry Analysis, Market Size, Share, Growth, Trends, and Forecast 2020 to 2027.

The global mycoplasma testing market is expected to grow from USD 0.66 billion in 2019 to USD 16.99 billion by 2027, at a CAGR of 12.5% during the forecast period 2020-2027. Asia-Pacific region is expected to show the highest share over the forecast period. It is due to increased funding by governments as well as a rise in the awareness. The Indian government is investing huge amount of money in enabling research and development activities in order to introduce new drugs. Moreover, favourable regulations related to improvements in biosafety quality by healthcare organizations are driving the growth of the market.

NOTE: Our analysts monitoring the situation across the globe explains that the market will generate remunerative prospects for producers post COVID-19 crisis. The report aims to provide an additional illustration of the latest scenario, economic slowdown, and COVID-19 impact on the overall industry.

DOWNLOAD FREE SAMPLE REPORT: https://www.fiormarkets.com/report-detail/418546/request-sample

Key players in the mycoplasma testing market are Lonza Group Ltd., PromoCell GmbH, Biological Industries Israel Beit Haemek Ltd, Thermo Fisher Scientific, InvivoGen, Charles River Laboratories International Inc., Merck KGaA, Bionique Testing Laboratories Inc. And American Type Culture Collection. Key players are emphasizing on various strategies such as geographical expansions, new product development, mergers and acquisitions. Charles River Laboratories International, Inc. expands its infrastructure for biologics testing solutions to release, characterization and development of biologics.
The technology segment includes enzymatic methods, microbial culture techniques, indirect assay, direct assay, ELISA and PCR. Direct assay segment is expected to show the highest growth over the forecast period. High level of certainty is expected to boost the growth of the segment. Microbial culture technique segment is also expected to show the highest growth as the mycoplasma testing has a broad range of applications along with a rise in the research activities in the biopharmaceutical industry. The application segment includes end of production cells testing, virus testing and cell line testing. End of production cells testing segment is expected to show the highest growth over the forecast period. It is due to a rise in clinical trials for drug development and discovery as well as increased cell harvest. It involves genetic analysis with the help of several techniques such as mRNA sequencing, transgene copy number and southern blotting.

Rise in the outsourcing is expected to drive the growth of the market. The expenditure on research and development is vast in the pharmaceutical industry. Biotechnology and pharmaceutical companies prefer to outsource functions like drug discovery, clinical trial management and manufacturing to contract research organizations. It is beneficial in minimizing the cost of an operation. Also, contract research organizations cater to multiple clients and can afford a considerable amount of investments in the drug discovery infrastructure. It is a cost-effective option which enables huge investments in cell line authentication, ELISA and PCR. Hence, the demand for mycoplasma testing is expected to increase from contract research organizations.

ACCESS FULL REPORT: https://www.fiormarkets.com/report/mycoplasma-testing-market-by-technology-enzymatic-methods-microbial-418546.html

About the report:
The global mycoplasma testing market is analyzed on the basis of value (USD Billion), volume (K Units), export (K Units), and import (K Units). All the segments have been analyzed on global, regional and country basis. The study includes an analysis of more than 30 countries for each segment. The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The study includes porter’s five forces model, attractiveness analysis, raw material analysis, and competitor position grid analysis.

Customization of the Report:
The report can be customized as per client requirements. For further queries, you can contact us on sales@fiormarkets.com or +1-201-465-4211. Our executives will be pleased to understand your requirements and offer you the best-suited reports.

Contact Us
Mark Stone
Phone: +1-201-465-4211
Email: sales@fiormarkets.com
Web: www.fiormarkets.com

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at contact@cdnnewswire.com.